109 related articles for article (PubMed ID: 23970159)
1. Roadmap for the European Network of Gynaecological Trial groups (ENGOT) Trials.
Vergote I; Elser G; Votan B; Farrelly L; De Roover J; Bryce J; du Bois A;
Int J Gynecol Cancer; 2013 Sep; 23(7):1339-43. PubMed ID: 23970159
[TBL] [Abstract][Full Text] [Related]
2. European Network of Gynaecological Oncological Trial Groups' Requirements for Trials Between Academic Groups and Industry Partners--First Update 2015.
du Bois A; Reuss A; Pujade-Lauraine E; Pignata S; Ledermann J; Casado A; Sehouli J; Mirza M; Colombo N; Marth C; Witteveen E; Del Campo J; Calvert P; Aravantinos G; Vardar MA; van der Zee AG; Korach J; Taskiran C; Fehr M; Glasspool R; Pfisterer J; Cibula D; Vergote I;
Int J Gynecol Cancer; 2015 Sep; 25(7):1328-30. PubMed ID: 26067859
[TBL] [Abstract][Full Text] [Related]
3. Joint ENGOT and GOG Foundation requirements for trials with industry partners.
Vergote I; Coleman RL; Pignata S; Bookman MA; Marth C; Herzog TJ; Gonzalez Martin A; Copeland LJ;
Int J Gynecol Cancer; 2019 Sep; 29(7):1094-1097. PubMed ID: 31320391
[No Abstract] [Full Text] [Related]
4. Joint ENGOT and GOG Foundation requirements for trials with industry partners.
Vergote I; Coleman RL; Pignata S; Bookman MA; Marth C; Herzog TJ; Gonzalez-Martin A; Copeland LJ; ;
Gynecol Oncol; 2019 Aug; 154(2):255-258. PubMed ID: 31331494
[No Abstract] [Full Text] [Related]
5. Report from the European Society of Gynaecological Oncology (ESGO) 2020 State-of-the-Art Virtual Meeting.
Razumova Z; Bizzarri N; Kacperczyk-Bartnik J; Pletnev A; Gonzalez Martin A; Persson J
Int J Gynecol Cancer; 2021 May; 31(5):658-669. PubMed ID: 33811109
[TBL] [Abstract][Full Text] [Related]
6. European Network of Gynaecological Oncological Trial Groups' requirements for trials between academic groups and pharmaceutical companies.
Vergote I; Pujade-Lauraine E; Pignata S; Kristensen GB; Ledermann J; Casado A; Sehouli J; Mirza M; Fossati R; Marth C; Creutzberg C; Del Campo J; Siddiqui N; Calvert P; Bamias A; Tulunay G; van der Zee AG; du Bois A;
Int J Gynecol Cancer; 2010 Apr; 20(3):476-8. PubMed ID: 20375816
[No Abstract] [Full Text] [Related]
7. The European society of gynaecological oncology: update on objectives and educational and research activities.
Brantnerova R; Manchanda R; Colombo N
Am Soc Clin Oncol Educ Book; 2012; ():335-8. PubMed ID: 24451759
[TBL] [Abstract][Full Text] [Related]
8. American Society of Clinical Oncology policy statement: oversight of clinical research.
American Society of Clinical Oncology
J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
[TBL] [Abstract][Full Text] [Related]
9. European Network of Gynaecological Oncological Trial Groups' requirements for trials between academic groups and industry partners - a new Model D for drug and medical device development.
Concin N; Ray-Coquard I; Glasspool RM; Braicu E; Farrelly L; Votan B; Mirza MR; Gonzalez Martin A; Vergote I; Pignata S
Int J Gynecol Cancer; 2020 Jun; 30(6):730-734. PubMed ID: 32404377
[No Abstract] [Full Text] [Related]
10. Erlotinib: CP 358774, NSC 718781, OSI 774, R 1415.
Adis International Ltd
Drugs R D; 2003; 4(4):243-8. PubMed ID: 12848590
[TBL] [Abstract][Full Text] [Related]
11. Report From the 20th Meeting of the European Society of Gynaecological Oncology (ESGO 2017).
Zalewski K; Piovano E; Razumova Z; Selcuk I; Nikolova T
Int J Gynecol Cancer; 2018 Jun; 28(5):1050-1053. PubMed ID: 29757877
[TBL] [Abstract][Full Text] [Related]
12. A European consistency for functioning of RECs? We just lost our chance.
Waligora M
J Med Ethics; 2013 Jun; 39(6):408-9. PubMed ID: 23222144
[TBL] [Abstract][Full Text] [Related]
13. Organization and ethical aspects of randomized trials in gynecologic oncology.
Vergote I
Verh K Acad Geneeskd Belg; 2000; 62(5):385-95; discussion 395-8. PubMed ID: 11144687
[TBL] [Abstract][Full Text] [Related]
14. Regulatory barriers to clinical trial enrollment of adolescent and young adult oncology patients.
Felgenhauer J; Hooke MC
Pediatrics; 2014 Jun; 133 Suppl 3():S119-22. PubMed ID: 24918210
[TBL] [Abstract][Full Text] [Related]
15. The European Network for Gynaecological Oncological Trial Groups Charta for Privileged Partnership.
Marth C; du Bois A; Schauer C; du Bois A; Casado A; Vergote I; del Campo JM; Goudopoulou A; Pujade-Lauraine E; Bruchim I; Colombo N; Pignata S; Ledermann J; Chekerov R; Raza Mirza M; Westermann A; Glasspool R; Taskiran C; Fehr M; Cibula D
Int J Gynecol Cancer; 2015 Jul; 25(6):1094-5. PubMed ID: 26098090
[No Abstract] [Full Text] [Related]
16. Towards a european network for multiple sclerosis trials (ENMST).
Kappos L; Polman C; Thompson AJ; Duda P; Clanet M; Comi G; Hartung HP; Montalban X
Mult Scler; 2003 Dec; 9(6):627-9. PubMed ID: 14664478
[TBL] [Abstract][Full Text] [Related]
17. [Development of anti-cancer drugs under new renewed GCP--from the viewpoint of drug development company developer].
Ueno T; Kobayashi T; Inoue K; Yanagi Y; Yamada Y
Gan To Kagaku Ryoho; 1998 Apr; 25(5):663-70. PubMed ID: 9571963
[TBL] [Abstract][Full Text] [Related]
18. Guideline on the design and conduct of cystic fibrosis clinical trials: the European Cystic Fibrosis Society-Clinical Trials Network (ECFS-CTN).
De Boeck K; Bulteel V; Tiddens H; Wagner T; Fajac I; Conway S; Dufour F; Smyth AR; Lee T; Sermet I; Kassai B; Elborn S;
J Cyst Fibros; 2011 Jun; 10 Suppl 2():S67-74. PubMed ID: 21658644
[TBL] [Abstract][Full Text] [Related]
19. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of clinical trials by Ethics Committees in Germany--results and a comparison of two surveys performed among members of the German Association of Research-Based Pharmaceutical Companies (vfa).
Russ H; Busta S; Jost B; Bethke TD
Ger Med Sci; 2015; 13():Doc02. PubMed ID: 25698912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
